Forty years ago, Cipla started its fight against heart disease with innovative and high-class drugs. We introduced Propranolol, the first beta blocker in India way back in 1972. This ushered in a new age of affordable beta blockers. Over the years, we have developed several products that help treat various diseases like MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, and obesity. Apart from innovation in cardiology, we also provide valuable services to the medical fraternity, in the form of the latest medical updates, CMEs and workshops. Not to mention many international symposia and webcasts with the world’s leading minds in cardiology, and conferences conducted in collaboration with international scientific bodies.
Besides, we are committed towards disease detection and patient awareness programmes like KBC (Know your Blood Cholesterol) and Check BP which can help doctors reach hundreds of undiagnosed patients and improve patient care and treatment adherence.
In the years to come, we shall continue to introduce novel drugs and combinations. We are also exploring the therapeutic potential of stem cells as part of our commitment to fight heart disease.